Search Results - "Dearnaley, D."

Further advances in orchid mycorrhizal research by Dearnaley, John D. W

“…Orchid mycorrhizas are mutualistic interactions between fungi and members of the Orchidaceae, the world's largest plant family. The majority of the world's…”
Get full text

Fertility, gonadal and sexual function in survivors of testicular cancer by HUDDART, R. A, NORMAN, A, MOYNIHAN, C, HORWICH, A, PARKER, C, NICHOLLS, E, DEARNALEY, D. P

“…Modern treatments cure most testicular cancer patients, so an important goal is to minimise toxicity. Fertility and sexual functioning are key issues for…”
Get full text

Nitrogen transport in the orchid mycorrhizal symbiosis – further evidence for a mutualistic association by Dearnaley, John D. W., Cameron, Duncan D.

“…This article is a Commentary on Fochi et al., 213: 365–379…”
Get full text

Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma by Horwich, A, Fossa, S D, Huddart, R, Dearnaley, D P, Stenning, S, Aresu, M, Bliss, J M, Hall, E

“…Background: Patients with stage I testicular seminoma are typically diagnosed at a young age and treatment is associated with low relapse and mortality rates…”
Get full text

SP-0011 IS DOSE ESCALATION APPROPRIATE? by Dearnaley, D

Get full text

Cardiovascular Disease as a Long-Term Complication of Treatment for Testicular Cancer by HUDDART, R. A, NORMAN, A, SHAHIDI, M, HORWICH, A, COWARD, D, NICHOLLS, J, DEARNALEY, D. P

“…To assess the risk of cardiovascular morbidity and cardiac risk factors in long-term survivors of testicular cancer according to treatment received. All…”
Get full text

Diversity and Antimicrobial Activity of Preussia sp. Endophytes Isolated from Australian Dry Rainforests by Mapperson, Rachel R, Kotiw, Michael, Davis, Rohan A, Dearnaley, John D. W

“…Limited knowledge currently exists regarding species diversity and antimicrobial activity of endophytic isolates of Preussia within Australia. This report…”
Get full text

Seven or less Fractions is Not the Standard of Care for Intermediate-Risk Prostate Cancer by Tree, A.C., Dearnaley, D.P.

“…Evidence is accumulating for seven and less fractions in localised prostate cancer, including one large randomised trial. However, there is much more evidence…”
Get full text

Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects by DEARNALEY, D. P, HALL, E, LAWRENCE, D, HUDDART, R. A, EELES, R, NUTTING, C. M, GADD, J, WARRINGTON, A, BIDMEAD, M, HORWICH, A

“…Radical radiotherapy is a standard form of management of localised prostate cancer. Conformal treatment planning spares adjacent normal tissues reducing…”
Get full text

Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC) by Molife, L. R., Attard, G., Fong, P. C., Karavasilis, V., Reid, A. H. M., Patterson, S., Riggs, C. E., Higano, C., Stadler, W. M., McCulloch, W., Dearnaley, D., Parker, C., de Bono, J. S.

“…Background: Histone deacetylase blockade can promote heat shock protein 90 (HSP90) acetylation, abrogating androgen receptor signaling. A phase II trial of the…”
Get full text

Neoadjuvant carboplatin before radiotherapy in stage IIA and IIB seminoma by Horwich, A., Dearnaley, D.P., Sohaib, A., Pennert, K., Huddart, R.A.

“…Extended field radiotherapy is a standard of care for low volume stage II testicular seminoma. We hypothesized that neoadjuvant carboplatin might reduce the…”
Get full text

Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours by O’Sullivan, J. M., Huddart, R. A., Norman, A. R., Nicholls, J., Dearnaley, D. P., Horwich, A.

“…Background: Bleomycin pulmonary toxicity (BPT) has been known since the early clinical trials of bleomycin in the 1960s. Postulated risk factors include…”
Get full text

Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes by Kote-Jarai, Z, Mikropoulos, C, Leongamornlert, D A, Dadaev, T, Tymrakiewicz, M, Saunders, E J, Jones, M, Jugurnauth-Little, S, Govindasami, K, Guy, M, Hamdy, F C, Donovan, J L, Neal, D E, Lane, J A, Dearnaley, D, Wilkinson, R A, Sawyer, E J, Morgan, A, Antoniou, A C, Eeles, R A

“…A rare recurrent missense variant in HOXB13 (rs138213197/G84E) was recently reported to be associated with hereditary prostate cancer. Population-based studies…”
Get full text

Evaluation of a multi-atlas CT synthesis approach for MRI-only radiotherapy treatment planning by Guerreiro, F, Burgos, N, Dunlop, A, Wong, K, Petkar, I, Nutting, C, Harrington, K, Bhide, S, Newbold, K, Dearnaley, D, deSouza, N.M, Morgan, V.A, McClelland, J, Nill, S, Cardoso, M.J, Ourselin, S, Oelfke, U, Knopf, A.C

“…Highlights • Establishing MRI-only RTP workflows requires synthetic CTs for dose calculation. • This study evaluates the feasibility of using a multi-atlas CT…”
Get full text

Hypofractionation for Prostate Cancer: Time to Change by Dearnaley, D, Syndikus, I, Gulliford, S, Hall, E

Get full text

Tumour responses following a steroid switch from prednisone to dexamethasone in castration-resistant prostate cancer patients progressing on abiraterone by Lorente, D, Omlin, A, Ferraldeschi, R, Pezaro, C, Perez, R, Mateo, J, Altavilla, A, Zafeirou, Z, Tunariu, N, Parker, C, Dearnaley, D, Gillessen, S, de Bono, J, Attard, G

“…Background: Abiraterone is a CYP17A1 inhibitor that improves survival in castration-resistant prostate cancer (CRPC). Abiraterone is licensed in combination…”
Get full text

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis by Edwards, S M, Evans, D G R, Hope, Q, Norman, A R, Barbachano, Y, Bullock, S, Kote-Jarai, Z, Meitz, J, Falconer, A, Osin, P, Fisher, C, Guy, M, Jhavar, S G, Hall, A L, O'Brien, L T, Gehr-Swain, B N, Wilkinson, R A, Forrest, M S, Dearnaley, D P, Ardern-Jones, A T, Page, E C, Easton, D F, Eeles, R A

“…Background: The germline BRCA2 mutation is associated with increased prostate cancer (PrCa) risk. We have assessed survival in young PrCa cases with a germline…”
Get full text

Older Age, Early Symptoms and Physical Function are Associated with the Severity of Late Symptom Clusters for Men Undergoing Radiotherapy for Prostate Cancer by Lemanska, A., Dearnaley, D.P., Jena, R., Sydes, M.R., Faithfull, S.

“…To identify symptom clusters and predisposing factors associated with long-term symptoms and health-related quality of life after radiotherapy in men with…”
Get full text

A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival by PARKER, C, MUSTON, D, MELIA, J, MOSS, S, DEARNALEY, D

“…The lead time and over-detection associated with prostate-specific antigen (PSA) screening, and generational improvements in all-cause mortality, make prostate…”
Get full text

Australia: A Continent Without Native Powdery Mildews? The First Comprehensive Catalog Indicates Recent Introductions and Multiple Host Range Expansion Events, and Leads to the Re-discovery of Salmonomyces as a New Lineage of the Erysiphales by Kiss, Levente, Vaghefi, Niloofar, Bransgrove, Kaylene, Dearnaley, John D. W., Takamatsu, Susumu, Tan, Yu Pei, Marston, Craig, Liu, Shu-Yan, Jin, Dan-Ni, Adorada, Dante L., Bailey, Jordan, Cabrera de Álvarez, Maria Graciela, Daly, Andrew, Dirchwolf, Pamela Maia, Jones, Lynne, Nguyen, Thuan Dat, Edwards, Jacqueline, Ho, Wellcome, Kelly, Lisa, Mintoff, Sharl J. L., Morrison, Jennifer, Németh, Márk Z., Perkins, Sandy, Shivas, Roger G., Smith, Reannon, Stuart, Kara, Southwell, Ronald, Turaganivalu, Unaisi, Váczy, Kálmán Zoltán, Blommestein, Annie Van, Wright, Dominie, Young, Anthony, Braun, Uwe

“…In contrast to Eurasia and North America, powdery mildews (Ascomycota, Erysiphales) are understudied in Australia. There are over 900 species known globally,…”
Get full text